To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Venous thromboembolism pr… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Venous thromboembolism prophylaxis in medical patients at Sahlgrenska University Hospital

Journal article
Authors K. Sandström
G. S. Guðnadóttir
Katarina Wilhelmson
H. L. Kristjánsdóttir
L. Stigendal
Published in Läkartidningen
Volume 114
Issue 22
ISSN 0023-7205
Publication year 2017
Published at Institute of Neuroscience and Physiology
Centre for Ageing and Health (Agecap)
Language sv
Subject categories Clinical Medicine


A hospitalized medical patient with risk factors has a 5-15 % risk of venous thromboembolism (VTE). Nonetheless thromboprophylaxis is largely underused. Our aim was to establish the proportion of high risk patients at Sahlgrenska University Hospital receiving thromboprophylaxis and to examine the 3-month incidence of VTE and bleeding. 198 patients were included and risk-stratified according to American College of Chest Physician guidelines. 12 % of high risk patients without and 26 % with increased bleeding risk received pharmacological thromboprophylaxis, as did 8 % of the patients without increased risk of VTE. VTE events occurred in 4.5 % of high risk patients, none received prophylaxis. Bleeding occurred in 5.8 % of those with increased bleeding risk. There is a need to improve thromboprophylaxis use to enhance patient safety and quality of care, for instance by issuing local guidelines. © 2017, Swedish Medical Association. All rights reserved.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?